Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· May 20, 2026

ASX Stocks Estimated To Be Undervalued By Up To 30.4%

View original at finance.yahoo.com
ASX Stocks Estimated To Be Undervalued By Up To 30.4% As the Australian market faces a cautious opening with expectations of a 20-point drop, driven by concerns over rising U.S…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Integral Diagnostics (ASX:IDX) is estimated to be undervalued by 48.3% based on cash flows, with current price A$2.04 vs fair value estimate A$3.95

    60% confidence
  • Acrow (ASX:ACF) is estimated to be undervalued by 44.5% based on cash flows, with current price A$0.785 vs fair value estimate A$1.42

    60% confidence
  • ALS is poised for substantial financial growth

    60% confidence
  • ALS Limited's current trading price of A$23.15 is approximately 10.8% below its estimated future cash flow value of A$25.96, suggesting potential undervaluation based on cash flows

    60% confidence
  • Despite a high level of debt, ALS is actively seeking acquisitions that align with its strategic goals and return hurdles, potentially enhancing shareholder value further

    60% confidence
  • Rising U.S. bond yields are driving concerns over potential price pressures in the Australian economy

    60% confidence
  • Symal Group (ASX:SYL) is estimated to be undervalued by 48.8% based on cash flows, with current price A$2.46 vs fair value estimate A$4.80

    60% confidence
  • ALS reported strong earnings growth of 24.4% over the past year

    60% confidence
  • NRW Holdings (ASX:NWH) is estimated to be undervalued by 45.4% based on cash flows, with current price A$7.06 vs fair value estimate A$12.93

    60% confidence
  • Judo Capital Holdings (ASX:JDO) is estimated to be undervalued by 47.6% based on cash flows, with current price A$1.315 vs fair value estimate A$2.51

    60% confidence
  • Light & Wonder (ASX:LNW) is estimated to be undervalued by 40.8% based on cash flows, with current price A$113.85 vs fair value estimate A$192.44

    60% confidence
  • ReadyTech Holdings (ASX:RDY) is estimated to be undervalued by 45.3% based on cash flows, with current price A$1.365 vs fair value estimate A$2.49

    60% confidence
  • Nuix (ASX:NXL) is estimated to be undervalued by 49.6% based on cash flows, with current price A$1.295 vs fair value estimate A$2.57

    60% confidence
  • SiteMinder (ASX:SDR) is estimated to be undervalued by 49.3% based on cash flows, with current price A$2.66 vs fair value estimate A$5.25

    60% confidence
  • Elsight (ASX:ELS) is estimated to be undervalued by 48.4% based on cash flows, with current price A$5.74 vs fair value estimate A$11.13

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com